Qualigen therapeutics, inc. reports fourth quarter and year-end 2022 financial results and provides corporate update

Carlsbad, calif., may 02, 2023 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn qualigen therapeutics, inc.), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, while also commercializing diagnostics, today announces financial results for the fourth quarter and fiscal year ended december 31, 2022, and provides an update on the company's therapeutics pipeline and other corporate developments.
QLGN Ratings Summary
QLGN Quant Ranking